Document Detail


Cognitive-behavioural therapy for severe mental disorders: back to the future?
MedLine Citation:
PMID:  18515887     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Like recent medication studies, it appears that when cognitive-behavioural therapy is tested in pragmatic effectiveness trials involving routine clinical populations it does not fare as well as in efficacy trials. Given the multitude of factors that can ;muddy the waters' in clinical trials, how do we best make sense of the findings?
Authors:
Jan Scott
Related Documents :
7041027 - Report on various clinical studies on high dose methotrexate in europe (non eortc).
17202897 - Herbal medicine for low back pain: a cochrane review.
19609887 - Some clinical trials get no respect.
18380637 - Practical guidelines for economic evaluations alongside equivalence trials.
4048757 - The visual analogue scale: its use in pain measurement.
444777 - Argon laser treatment of decorative tattoos.
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  The British journal of psychiatry : the journal of mental science     Volume:  192     ISSN:  0007-1250     ISO Abbreviation:  Br J Psychiatry     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-02     Completed Date:  2008-09-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0342367     Medline TA:  Br J Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  401-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / therapeutic use*
Cognitive Therapy* / trends
Humans
Mental Disorders / therapy*
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Antipsychotic Agents
Comments/Corrections
Comment On:
Br J Psychiatry. 2008 Jun;192(6):412-23   [PMID:  18515890 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis.
Next Document:  Communication and psychosis: it's good to talk, but how?